PAR 1.72% 29.5¢ paradigm biopharmaceuticals limited..

Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-45

  1. 212 Posts.
    lightbulb Created with Sketch. 42
    orphan drug status is a real deal, worth a huge amount , that's really not to be discounted .
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.005(1.72%)
Mkt cap ! $99.69M
Open High Low Value Volume
28.5¢ 29.5¢ 28.5¢ $70.12K 241.3K

Buyers (Bids)

No. Vol. Price($)
2 17637 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 10617 4
View Market Depth
Last trade - 13.28pm 08/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.